Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats

British Journal of Pharmacology

Volumn 121, Issue 5, 1997, Pages 935-940

  Schiffrin, Ernesto L ^a   Turgeon, André ^a   Deng, Li Y ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

A 127722.5; Angiotensin converting enzyme inhibition; Blood vessels; DOCA salt hypertensive rats; Endothelin 1 gene expression; LU 135252; One kidney one clip Goldblatt hypertensive rats; Renin angiotensin system; Spontaneously hypertensive rats (SR)

Indexed keywords

2 (4 METHOXYPHENYL) 4 (1,3 BENZODIOXOL 5 YL) 1 [(N,N DIBUTYLAMINO)CARBONYLMETHYL]PYRROLIDINE 3 CARBOXYLIC ACID; 2 (4,6 DIMETHOXYPYRIMIDIN 2 YL OXY) 3 METHOXY 3,3 DIPHENYLPROPIONIC ACID; ATRASENTAN; CILAZAPRIL; DARUSENTAN; DEOXYCORTICOSTERONE ACETATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; GENE EXPRESSION; HEREDITARY HYPERTENSION; HYPERTENSION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION;

EID: 0030925245     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701224     Document Type: Article

References (34)

1. A) receptor antagonist in conscious rats. J. Cardiovasc. Pharmacol., 20, 940-948.
2. BIRD, J.E., MORELAND, S., WALDRON, T.L. & POWELL, J.R. (1995). Antihypertensive effects of a novel endothelin-A receptor antagonist in rats. Hypertension, 25, 1191-1195.
3. BOBIK, A., GROOMS, A., MILLAR, J.A., MITCHELL, A. & GRINPUKEL, S. (1990). Growth factor activity of endothelin on vascular smooth muscle. Am. J. Physiol., 258, C408-C415.
4. CHUA, B.H.L., KREBS, C.J., CHUA, C.C. & DIGLIO, C.A. (1992). Endothelin stimulates protein synthesis in smooth muscle cells. Am. J. Physiol., 262, E412-E416.
5. CLOZEL, M., BREU, V., GRAY, G.A., KALINA, B., LÖFFLER, B.-M., BURRI, K., CASSAL, J.-M., HIRTH, G., MULLER, M., NEIDHART, W. & RAMUZ, H. (1994). Pharmacological characterization of bosentan, a new potent orally active non-peptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther., 270, 228-235.
6. DAY, R., LARIVIÈRE, R. & SCHIFFRIN, E.L. (1995). In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Am. J. Hypertens., 8, 294-300.
7. DOHI, Y., HAHN, A.W.A., BOULANGER, C.M., BÜHLER, F.R. & LÜSCHER, T.F. (1992). Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension, 19, 131-137.
8. IMAI, T., HIRATA, Y., EMORI, T., YANAGISAWA, M., MASAKI, T. & MARUMO, F. (1992). Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension, 19, 753-757.
9. KAUFMANN, H., ORIBE, E. & OLIVER, J.A. (1991). Plasma endothelin during upright tilt: relevance for orthostatic hypotension. Lancet, 338, 1542-1545.
10. LARIVIÈRE, R., DAY, R. & SCHIFFRIN, E.L. (1993a). Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Hypertension, 21, 916-920.
11. LARIVIÈRE, R., SVENTEK, P., THIBAULT, G. & SCHIFFRIN, E.L. (1995). Expression of endothelin-1 gene in blood vessels of adult spontaneously hypertensive rats. Life Sci., 56, 1889-1896.
12. LARIVIÈRE, R., THIBAULT, G. & SCHIFFRIN, E.L. (1993b). Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension, 21, 294-300.
13. LI, J.-S., KNAFO, L., TURGEON, A., GARCIA, R. & SCHIFFRIN, E.L. (1996). Effect of endothelin antagonism on blood pressure and vascular structure in renovascular hypertensive rats. Am. J. Physiol. (Heart Cic. Physiol.), 40, H88-H93.
14. LI, J.S., LARIVIÈRE, R. & SCHIFFRIN, E.L. (1994). Effect of a non selective endothelin antagonist on vascular remodeling in DOCA-salt hypertensive rats. Evidence of a role in vascular hypertrophy. Hypertension, 24, 183-188.
15. LI, J.-S. & SCHIFFRIN, E.L. (1995a). Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist. Hypertension, 25 [Part 1], 495-500.
16. LI, J.-S. & SCHIFFRIN, E.L. (1995b). Chronic endothelin receptor antagonist treatment of young spontaneously hypertensive rats. J. Hypertens., 13, 647-652.
17. LI, J.-S. & SCHIFFRIN, E.L. (1996). Effect of calcium channel blockade or angiotensin converting enzyme inhibition on structure of coronary, renal and other small arteries in SHR. J. Cardiovasc. Pharmacol., 28, 68-74.
18. LÖFFLER, B.-M., BREU, V. & CLOZEL, M. (1993). Effect of endothelin receptor antagonists and of the novel non-peptide antagonist Ro 46-2005 on endothelin levels in rat plasma. FEBS Lett., 333, 108-110.
19. LÜSCHER, T.F., SEO, B., BÜHLER, F.R. (1993). Potential role of endothelin in hypertension. Hypertension, 21, 752-757.
20. MÜENTER, K., HERGENRÖDER, S., UNGER, L. & KIRCHENGAST, M. (1996). Oral treatment with an ETA-receptor antagonist inhibits neointima formation induced by endothelial injury. Pharm. Pharmacol. Lett., 6, 90-92.
21. A-selective receptor antagonist. J. Pharmacol. Exp. Ther., 276, 473-481.
22. ORMSBEE, H.S. & RYAN, C.F. (1973). Production of hypertension with deoxycorticosterone acetate-impregnated silicone rubber implants. J. Pharmacol. Sci., 62, 255-257.
23. RICHARD, V., HOGIE, M., CLOZEL, M., LÖFFLER, B.-M. & THUILLEZ, C. (1995). In vivo evidence of an endothelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation, 91, 771-775.
24. RIECHERS, H., ALBRECHT, H.P., AMBERG, W., BAUMANN, E., BERNARD, H., BOHM, H.J., KLINGE, D., KLING, A., MULLER, S., RASCHACK, M., UNGER, L., WALKER, N. & VERNET, W. (1996). Discovery and optimization of a novel class of orally active non peptidic endothelin-A receptor antagonists. J. Med. Chem., 39, 2123-2128.
25. SCHIFFERS, P.M.H., FAZZI, G.E., VAN INGEN SCHENAU, D. & DE MEY, J.G.R. (1994). Effects of candidate autocrine and paracrine mediators on growth responses in isolated rat arteries. Arterioscler. Thromb., 14, 420-426.
26. SCHIFFRIN, E.L. (1995). Endothelin, potential role in hypertension and vascular hypertrophy. Brief review. Hypertension, 25, 1135-1143.
27. SCHIFFRIN, E.L., LARIVIÈRE, R., LI, J.-S. & SVENTEK, P. (1996). Enhanced expression of endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure. J. Vasc. Res., 33, 235-248.
28. SCHIFFRIN, E.L., LARIVIÈRE, R., LI, J.-S., SVENTEK, P. & TOUYZ, R.M. (1995a). Deoxycorticosterone acetate plus salt induce overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats. Hypertension, 25, [Part 2], 769-773.
29. B endothelin receptor antagonist, in DOCA-salt spontaneously hypertensive rats. Br. J. Pharmacol., 115, 1377-1381.
30. SVENTEK, P., LI, J.-S., GROVE, K., DESCHEPPER, C.F. & SCHIFFRIN, E.L. (1996a). Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats. Hypertension, 27, 49-55.
31. SVENTEK, P., TURGEON, A., GARCIA, R. & SCHIFFRIN, E.L. (1996b). Vascular and cardiac overexpression of endothelin-1 gene in 1-kidney, one clip Goldblatt hypertensive rats but only in the late phase of 2-kidney, 1 clip Goldblatt hypertension. J. Hypertens., 14, 57-64.
32. SVENTEK, P., TURGEON, A. & SCHIFFRIN, E.L. (1997). Vascular endothelin-1 gene expression and effect on blood pressure of chronic ETA endothelin receptor antagonism after nitric oxide synthase inhibition with L-NAME in normal rats. Circulation, 95, 240-244.
33. VANHOUTTE, P.M. (1993). Is endothelin involved in the pathogenesis of hypertension? Hypertension, 21, 747-751.
34. YANAGISAWA, M., KURIHARA, H., KIMURA, S., TOMOBE, Y., KOBAYASHI, M., MITSUI, Y., YAZAKI, Y., GOTO, K. & MASAKI, T. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 332, 411-415.